Company

Medifocus, Inc. develops cancer treatment systems that use focused heat to kill cancerous tumors. The Company is currently developing and commercializing focused heat treatment systems using a proprietary adaptive phased array (APA) thermotherapy technology platform licensed from the Massachusetts Institute of Technology (MIT). The systems provide focused thermotherapy to reduce or eradicate tumors using an intensely focused microwave energy beam at tumor sites. The Company's goal is to improve outcomes and standards of care for cancer treatment.